All Articles

Gartner's nod to Ez-XBRL is more than an award. It marks a shift to AI-native platforms that promise to turn the burden of compliance into a strategic asset.

Atlantic Home Mortgage's new AI platform, Lendtrain, offers 30-second refi quotes. Its true innovation is a strategic shift from interest rates to break-even.

As Helius Minerals pushes to acquire Brazil's legendary Serra Pelada mine, a rival's legal victory resurrects old claims. But what does the ruling truly mean?

Amid soaring losses and a strategic overhaul, Core AI's appointment of CFO Arie Goor signals a critical bet on financial discipline to fuel its AI ambitions.

A Malaysian hotpot chain lands a massive data center deal, but with no tech experience and a plunging stock price, is this a brilliant pivot or a desperate gamble?

AstraZeneca's new deal with genomics firm Helix isn't just a partnership; it's a bet on a future where drug discovery is driven by massive data vaults.

With €33M in fresh capital, Cyllene Therapeutics is advancing a novel gene therapy for bladder disease. We analyze the tech, the investors, and the plan.

Presage Technologies' new FDA-cleared app turns any phone into a vital signs monitor, offering it free to hospitals to democratize healthcare access.

Lopesan Hotel Group just opened a massive three-resort complex in Punta Cana. Is it a new benchmark for luxury or a gamble too big to manage?

With its new Waybound™ brand, Delaware North is redefining outdoor lodging, blending upscale comfort with authentic nature experiences for discerning travelers.

A $170M recapitalization of Lone Peak Dental Group isn't just finance. It's a test of whether private credit can expand vital care for underserved kids.

Oregon's Tillamook isn't just winning awards; it's executing a masterclass in product innovation and brand strategy to challenge dairy giants.

The appointment of Robert Tidd is more than a new hire; it's a calculated move to master AI governance and redefine trust in a complex digital landscape.

Known for its athletic tape, KT is making a strategic leap into the crowded OTC pain relief aisle. Is this a brilliant brand extension or a risky bet?

Strong Q2 results reveal how metallurgical tweaks and plant optimizations in Latin America are driving record output and lifting Mineros' 2026 outlook.

XBOW's new AWS Security Competency isn't just a badge. It marks a critical shift to autonomous, AI-driven defense against AI-accelerated threats.

Lumanity's aggressive, science-based emissions targets are not just for the planet—they are a calculated move to win business in the demanding biopharma sector.

For millions with the debilitating condition dysautonomia, diagnosis is a long, frustrating journey. A new technology promises to replace subjective guesswork with hard data.

As federal deadlines for quantum-proof security loom, a retired Navy admiral joins a tech firm. This isn't just a new job; it's a national security race.

Pediatrica Health's $28M Series B aims to fix a broken system. With investors betting on 'equitable access,' is this the future of child healthcare?